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The Impact of Functional Status at Three Months on
Long-Term Survival After Spontaneous
Intracerebral Hemorrhage
Pertti Saloheimo, MD, PhD; Tuuli-Maaria Lapp, MD; Seppo Juvela, MD, PhD; Matti Hillbom, MD, PhD
Background and Purpose—Few studies have assessed long-term prognosis and risk factors for death after spontaneous
intracerebral hemorrhage (ICH). Patients who survive the acute phase may run different prognoses, depending on their
disability, treatment, and lifestyle. The present study was performed to find out the predictors for long-term mortality
after ICH.
Methods—We assessed 7-year prognosis in a population-based cohort of patients who had survived the first 3 months after
ICH (n140). Controls (n206) living in the same geographical area were randomly drawn from the population register
and followed up for the same time.
Results—Seven-year mortality was significantly higher in ICH patients than in controls (32.9 and 19.4%, respectively;
P0.0034). The annual risk for death in ICH patients was 5.6%, and the annual risk for fatal recurrent ICH was 1.3%.
The ICH patients with good recovery at 3 months showed similar risk for death as controls. Recurrent ICH and
pneumonia were the most common causes of death in ICH patients. Cigarette smoking, age, and diabetes seemed to
increase the risk for death in patients and controls.
Conclusions—Survivors of ICH run a higher long-term risk for death than age- and sex-matched controls. However, those
who show good recovery at 3 months run a similar outcome as controls. (Stroke. 2006;37:487-491.)
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Long-term survival after spontaneous intracerebral hem-orrhage (ICH) has been reported to be 20% to 40% at
2 years after the index stroke.1–3 The predictors for long-term
(6 months) survival after ICH include the initial level of
consciousness, the severity of the handicap caused by the
stroke in the early phase, the patient’s age, and hematoma
volume and location.4–9
We followed a cohort of ICH patients for 7 years after the
index stroke to assess long-term mortality after ICH and to
determine the predictors for death during this extended
follow-up. We compared the survival of the patients with the
survival of control subjects randomly drawn from the popu-
lation register of Finland and living in the same geographical
area, who were followed up for the same period.
Subjects and Methods
The present study series was drawn from a population-based cohort
including all incident cases of spontaneous ICH in the catchment
area of Oulu University Hospital between January 1993 and Sep-
tember 1995 (n208). Oulu University Hospital is the only hospital
serving acute stroke patients in Northern Ostrobothnia, Finland
(population 356 026). We excluded the patients not living in the
catchment area of the hospital and those who had a brain tumor,
aneurysm, vascular malformation, hematological malignancy, coag-
ulation disorder, or head trauma. ICH was verified by head computed
tomography (CT) scanning or at autopsy in all cases, and secondary
structural abnormalities were searched for by repeated brain imaging
(CT or MRI) 3 months after the bleed. Angiography was performed
if location of ICH suggested occurrence of an aneurysm.
Included were the 140 patients who survived for the first 3 months
after ICH. They all were admitted into Oulu University Hospital and
followed up for 7 years or until death. Controls were 206 subjects
randomly drawn from the population register of the catchment area
of Oulu University Hospital who were matched for age (3 years)
and sex for the originally 98 ICH patients admitted into the
Department of Neurology. Ten controls refused, and other randomly
drawn subjects were interviewed instead. Informed consent was
obtained from the patients/proxies and control subjects, and the study
protocol was approved by the ethics committee of the hospital.
Ninety of the patients were treated at the Department of Neurol-
ogy, whereas the others were treated at the Department of Neuro-
surgery or at the Department of Internal Medicine. Data of the
patients’ previous diseases, blood pressure histories, medications,
and lifestyle factors were gathered by interviewing the patients or
their proxies during the inpatient period according to a structured
protocol for those who were treated at the Department of Neurology.
Data were extracted according to the same protocol from the hospital
records of the other patients. Medical complications such as myo-
cardial infarction, heart failure, cardiac arrhythmias, infection, deep
vein thrombosis, and pulmonary embolism during hospitalization
were recorded, as were neurosurgical interventions (evacuation of
the hematoma was performed on 18 patients and ventriculostomy on
3 patients). The time of ICH onset was defined to be the acute onset
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of headache or neurological deficit. The control subjects were
interviewed via telephone during the recruitment period by the same
person (P.S.) using the same structured questionnaire. In addition,
informed consent was obtained from the controls for reviewing their
previous hospital records to check for diseases, medication, and
blood pressure histories. Records were available for 166 (81%) of the
controls.
Subjects were considered to be hypertensive if their blood pressure
readings preceding the index stroke had at least twice exceeded
160/95 mm Hg, or if they were taking antihypertensive medication.
The patients were recorded as having diabetes mellitus if they used
oral hypoglycemic agents or insulin. Previous hemorrhagic strokes
(ICH and subarachnoid hemorrhage) as well as ischemic strokes
were recorded. Cardiac disease included myocardial infarction,
coronary artery disease, heart failure, and atrial fibrillation. Gastro-
intestinal bleeding and hematuria in the patients’ history were
recorded as bleeding disorders. Heavy drinking of alcohol was
determined as described previously.10 However, for the 50 patients
treated at other departments of our hospital, the data on drinking
habits were gathered from hospital records. The subjects were
categorized as current cigarette smokers and nonsmokers. The
patients’ functional outcome at 3 months was assessed according to
the Glasgow Outcome Scale (GOS)11 on scheduled follow-up visits
to the hospital 3 months after the ICH. Survival of the patients and
controls during the 7-year follow-up was checked from the Causes of
Death Register (Statistics Finland). The immediate cause of death
(eg, pneumonia, not ICH) was always used in the analyses.
Categorical variables were compared by Fisher exact 2-tailed test
and Pearson 2 test. Continuous variables were compared between
the groups by the Mann–Whitney U test, Student t test, and ANOVA.
For life-table analysis and the Cox proportional hazards regression
model, each patient and control subject was followed to death or
until 7 years. Cumulative survival rates were estimated by the
Kaplan–Meier product-limit method, and the curves of the different
groups were compared by the log-rank test. The Cox proportional-
hazards model with a forward stepwise-regression procedure served
to determine the significance of several variables in predicting
relative risks and 95% CIs for death. These variables, known at the
beginning of follow-up, were as follows: age; sex; history of
hypertension, ischemic or hemorrhagic stroke, cardiac disease, dia-
betes, and cancer; GOS score at 3 months after ICH; warfarin
treatment; regular aspirin use; bleeding disorders; current smoking;
and heavy alcohol drinking. The assumption of proportionality was
checked. The test for significance was based on changes in the log
(partial) likelihood. A 2-tailed P value of0.05 was considered to be
statistically significant.
Results
The baseline characteristics and health habits of the cases and
controls are shown in Table 1. Hypertension, especially
untreated hypertension, was significantly more common in
patients than controls.
Cumulative survival of the patients with ICH and controls
are shown in Figure 1. The total follow-up period was 820
person years for patients and 1319 for controls. Annual risk
for death during follow-up was 5.6% for patients and 3.0%
for controls. The 7-year mortality rate was significantly
higher among ICH patients than controls (32.9% and 19.4%,
respectively; P0.0034). In our original cohort of 208
subjects with ICH, the overall 7-year mortality was 54.8%.
According to GOS, 52 patients (37.1%) showed good
recovery, 27 (19.3%) were moderately disabled, and 61
(43.6%) were severely disabled at the beginning of the
follow-up. Figure 2 shows the cumulative survival rates of
these groups. The mortality of the patients who were severely
disabled according to GOS was significantly higher than that
of the patients who showed good recovery (P0.0056).
Those who showed good recovery at 3 months ran a similar
outcome as controls (P0.84).
The causes of death among patients and controls are shown
in Table 2. Significantly more patients (7.9%) than controls
(1.0%) died of ICH (P0.002). The annual risk for fatal
recurrent ICH was 1.3% in our cohort. Recurrent ICH and
pneumonia were the most common causes of death in ICH
patients, killing 8% and 10% of the patients, respectively.
Mortality attributable to pneumonia was directly associated
TABLE 1. Baseline Characteristics of 140 Patients With ICH
and 206 Controls
Characteristics ICH Control
Men, n (%) 74 (52.9) 121 (58.7)
Mean age, y (SD) 65.9 (10.3) 65.8 (10.5)
Mean body mass index, kg/m2 (SD) 27.5 (5.5) 26.5 (4.0)
Previous diseases, n (%)
Hypertension 92 (65.7) 103 (50.0)*
Hypertension treated 60 (42.9) 85 (41.3)
Hypertension untreated 32 (22.9) 18 (8.7)†
Cardiac disease 48 (34.3) 70 (34.0)
Ischemic stroke 21 (15.0) 19 (9.2)
Hemorrhagic stroke 14 (10.0) 1 (0.5)
ICH 8 (5.7) 0
Subarachnoid hemorrhage 6 (4.3) 1 (0.5)
Gastrointestinal bleeding 12 (8.6) 24 (11.7)
Hematuria 10 (7.1) 20 (9.7)
Cancer 17 (12.1) 14 (6.8)
Diabetes mellitus 11 (7.9) 17 (8.3)
Lifestyle factors, n (%)
Current heavy drinking 23/123 (18.7) 47 (22.8)
Current smoking 15 (10.7) 33 (16.0)
Medication (before index stroke)
Aspirin 25 (17.9) 42 (20.4)
Warfarin 7 (5.0) 5 (2.4)
*P0.003; †P0.001.
Figure 1. Seven-year survival of patients with ICH and controls.
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with the GOS score at 3 months (P0.026). Eleven (5.3%)
controls died of pneumonia, but the difference in mortality
from pneumonia between the patients and controls did not
reach statistical significance (P0.064). Eight patients
(5.7%) with ICH and 11 control subjects (5.8%) died of
myocardial infarction or other cardiac causes.
Independent significant predictors for death during the
follow-up in patients and controls are shown in Table 3.
Smoking was a significant predictor for mortality in both
groups, whereas diabetes reached significance only in pa-
tients. Age was significantly associated with mortality in
controls but not in patients.
Discussion
The mortality of the patients who had survived for 3 months
after ICH was significantly higher than that of controls during
a follow-up of 7 years. The increased mortality of ICH
patients compared with controls was attributable to rebleed-
ings and pneumonia. However, the mortality rates differed
significantly according to the GOS score at 3 months after
ICH. Mortality was highest among the severely disabled ICH
patients, pneumonia being their most common cause of death.
On the other hand, the patients with good recovery at 3
months after ICH survived equally to controls. Smoking was
a significant preventable risk factor for death in ICH patients
and controls.
To our knowledge, the long-term survival of patients with
ICH has not before been compared with the survival of a
prospectively followed cohort of control subjects from the
same population. We found that patients with ICH show
excess mortality after the first 3 months up to 7 years. There
is only 1 previous study suggesting a similar finding in ICH
patients.2 The Oxfordshire Community Stroke Project com-
pared the risk of death for stroke patients with that for people
of similar age and sex from the general population. A higher
than expected mortality rate among those who survived
beyond the first month was observed in ICH patients, the
average annual risk of death being 8% during a follow-up of
5 years. The annual risk for death was slightly lower (5.6%)
in our study. A previous Finnish study also compared the
survival of ICH patients to the probability of survival in a
general population of similar age and sex.1 In that study, the
long-term prognosis up to 5 years of the ICH patients who
survived for the first month did not differ from that of the
average Finnish population. In other studies, the patient series
have consisted of hospitalized patients, controls have been
lacking, or the observation periods have been shorter than 2
years.
We observed a lower long-term mortality after ICH than
reported previously.1–3 Fogelholm et al reported a 65%
mortality rate during a median follow-up of 2.7 years in
central Finland in the 1980s.1 However, recently, a decline in
mortality from ICH in Finland has been observed.12–14 Im-
proved acute care of stroke patients, which allows more
patients with moderate-to-severe disability to survive beyond
the first critical days, may explain somewhat lower mortality
in our study compared with some previous ones.1,12
TABLE 2. Causes of Death of Patients With Spontaneous ICH Who Survived the First 3
Months and Controls During 7-Year Follow-up
Variable
GOS at the Beginning
of Follow-up
ICH Control
Good
Recovery
Moderate
Disability
Severe
Disability Total
Died during follow-up (%) 11/52 (21.2) 8/27 (29.6) 27/61 (44.3) 46/140 (32.9) 40/206 (19.4)
Cause of death
ICH 4 1 6 11 2
Ischemic stroke 0 2 1 3 1
Pneumonia 2 2 10 14 11
Cardiac disease 2 1 5 8 12
Trauma 0 0 2 2 1
Cancer 1 0 0 1 4
Pulmonary embolism 0 0 0 0 1
Miscellaneous 2 2 3 7 8
Figure 2. Seven-year survival of patients with ICH according to
the GOS score. Forty-one (78.8%), 19 (70.4%), and 43 (55.7%)
patients with good recovery, moderate disability, and severe
disability at the beginning of follow-up, respectively, survived for
7 years.
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Our study indicates that mortality during long-term
follow-up is significantly higher in patients who are severely
disabled according to GOS at 3 months after the index stroke
compared with those who show good recovery. Pneumonia as
a cause of death was most common in the severely disabled
patients, probably being a complication of immobility. The
moderately disabled also showed somewhat higher mortality
than those with good recovery. In previous studies, the
severity of stroke assessed by the initial level of conscious-
ness according to the Glasgow Coma Scale score15 on
admission and the handicap caused by the stroke according to
the modified Rankin scale16 in the early phase were shown to
predict long-term mortality after ICH.5–9 Stroke severity
predicts functional outcome and residual disability similarly
in ischemic and hemorrhagic strokes.17 Our findings suggest
that the functional status reached after rehabilitation may be
a major factor determining future survival.
Diabetes and current smoking predicted long-term mortal-
ity of ICH patients in our study. These are novel findings. In
2 previous studies, diabetes was shown to be an independent
risk factor for in-hospital mortality from ICH.18,19 Lifestyle
factors have been analyzed in very few studies of survival
after ICH. Alcohol consumption within a week before ICH
has been shown to predict poor functional outcome, but it did
not significantly associate with 1-year mortality.6 Nor did
heavy drinking of alcohol associate with mortality in our
study. Smoking also predicted death in the group of healthy
controls.
Patient age tended to predict mortality in our cohort of ICH
patients who survived the first 3 months after the stroke, but
the association was not significant. In a number of previous
studies, patient age has been found to significantly predict
long-term survival after ICH.1,5,7–9,20 However, Juvela did not
find patient age to predict mortality within 1 year after ICH.6
Hematoma volume8 and location4,6 have also been associated
with long-term survival after ICH.
Recurrent ICH accounted for 24% of deaths among pa-
tients. An annual recurrence rate of 2.4% for ICH has been
reported,21 but because of our study design, we were only
able to detect fatal rebleedings. The prognosis after recurrent
ICH has been shown to be worse than that after the first ICH,
and in-hospital mortality from 32% to 56% after the second
ICH has been reported.22,23 Rebleedings have been observed
to associate with poor control of hypertension.22,23 Therefore,
adequate control of hypertension is probably the most impor-
tant primary and also secondary prophylaxis of ICH. How-
ever, some patients may have other, undetected risk factors
that are difficult to target. The 2 or 4 alleles of the
apolipoprotein E gene have been shown to increase the risk
for recurrent lobar ICH attributable to cerebral amyloid
angiopathy.24
The strengths of the study include the population-based
design and the complete follow-up of patients and controls.
The causes of death were extracted from the Causes of Death
Register of Finland, which is considered a reliable source of
data.25 However, the findings about predictors for long-term
survival must be interpreted with caution because the patient
data (eg, lifestyle data) were collected during the period of
hospitalization attributable to the index stroke and are thus
indicative of the patients’ preictal health habits. Some of the
smokers probably gave up smoking after the index stroke. In
consequence, not all of the patients classified as smokers
continued smoking during the follow-up years. However, if
these previous smokers had been classified as nonsmokers,
the association between smoking and excess mortality might
have been even stronger. In addition, case findings may have
been incomplete for 3 reasons. First, some elderly subjects
dying outside our hospital may have died of ICH without
verification by head CT or autopsy. Second, those subjects
who may have had an ICH when on holiday were not
included previously. However, if such a patient was trans-
ferred to our hospital during the acute phase, he/she was
included. Third, we may have missed subjects with mild
strokes who were not admitted or who were admitted so late
that ICH was no longer detectable by CT. However, the
proportion of possible missing cases is likely low and does
not affect the reliability of our study. The different methods
used for obtaining data of cases and controls and of cases
admitted to different departments of our hospital are another
limitation. However, we believe that current diseases, such as
hypertension and diabetes, as well as smoking status were
accurately recorded in patient charts. In addition, telephone
interview has been found to be a method comparable to
personal interview for assessing smoking status.26
In conclusion, we found increased long-term mortality in
patients with ICH who had survived the first 3 months after
the stroke compared with controls. Excess mortality was
especially marked among the ICH patients who were severely
disabled at 3 months after ICH, and it was mainly because of
pneumonia, which is a complication of immobility. Rebleed-
ings were also quite common but unrelated to the grade of
disability. Our observations suggest that more attention
should be paid to the prevention of infections and the
treatment of cardiovascular risk factors such as hypertension,
TABLE 3. Multivariate Relative Risks of Death During 7-Year Follow-up in
Patients With ICH and Controls
Variable
ICH Controls
Relative Risk* 95% CI P Relative Risk* 95% CI P
Age 1.04 0.99–1.09 0.084 1.16 1.10–1.21 0.001
Diabetes 3.62 1.27–10.29 0.016 2.41 0.91–6.39 0.077
Smoking 3.09 1.30–7.36 0.011 2.73 1.03–7.19 0.043
*Relative risks have been adjusted for sex and the variables listed in the table and, in patients, also
for GOS score at the beginning of follow-up (3 months after the onset of the index stroke).
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diabetes, and smoking in patients surviving their first ICH.
Active treatment in the acute phase and rehabilitation may
improve not only the short-term outcome but also long-term
survival.
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